FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045851521> ?p ?o ?g. }

• W2045851521 endingPage "134" @default.
• W2045851521 startingPage "129" @default.
• W2045851521 abstract "We previously reported results of a phase II non-comparative trial that randomized patients with glioblastoma following radiotherapy to one of two different temozolomide schedules, followed by 13-cis-retinoic acid (RA) maintenance. Here we report the results of an exploratory cohort of patients accrued with anaplastic astrocytic tumors. Patients with newly diagnosed anaplastic astrocytoma (AA) or anaplastic oligo-astrocytoma (AOA) were treated with concurrent radiotherapy (60 Gy over 6 weeks) and temozolomide (75 mg/m(2)), and six adjuvant 28-day cycles of either dose-dense (150 mg/m(2), days 1-7, 15-21) or metronomic (50 mg/m(2), days 1-28) temozolomide. Subsequently, maintenance RA (100 mg/m(2), days 1-21/28) was administered until disease progression. All outcome measures were descriptive without intention to compare between treatment arms. Survival was measured by the Kaplan-Meier method. There were 31 patients (21 men, 10 women) with median age 48 years (range 28-74), median KPS 90 (range 60-100). Extent of resection was gross-total in 35%, subtotal 23%, and biopsy 42%. Histology was AA in 90%, and AOA in 10%. MGMT promoter methylation was methylated in 20%, unmethylated in 50%, and uninformative in 30% of 30 tested. Median progression-free survival was 2.1 years (95% CI 0.95-Not Reached), and overall survival 2.9 years (95 % CI 2.0-Not Reached). We report outcomes among a homogeneously treated population with anaplastic astrocytic tumors. Survival was unexpectedly short compared to other reports. These data may be useful as a contemporary historic control for other ongoing or future randomized trials." @default.
• W2045851521 created "2016-06-24" @default.
• W2045851521 creator A5000349777 @default.
• W2045851521 creator A5002965160 @default.
• W2045851521 creator A5009476786 @default.
• W2045851521 creator A5018451725 @default.
• W2045851521 creator A5024476694 @default.
• W2045851521 creator A5039932065 @default.
• W2045851521 creator A5057541817 @default.
• W2045851521 creator A5070190752 @default.
• W2045851521 creator A5084965180 @default.
• W2045851521 date "2015-04-29" @default.
• W2045851521 modified "2023-10-16" @default.
• W2045851521 title "Radiotherapy and temozolomide for anaplastic astrocytic gliomas" @default.
• W2045851521 cites W1959628099 @default.
• W2045851521 cites W1971163516 @default.
• W2045851521 cites W1971951959 @default.
• W2045851521 cites W1973864599 @default.
• W2045851521 cites W1984955359 @default.
• W2045851521 cites W1996908572 @default.
• W2045851521 cites W2003123373 @default.
• W2045851521 cites W2006036234 @default.
• W2045851521 cites W2009816439 @default.
• W2045851521 cites W2060468178 @default.
• W2045851521 cites W2066343654 @default.
• W2045851521 cites W2079786467 @default.
• W2045851521 cites W2096287682 @default.
• W2045851521 cites W2102866582 @default.
• W2045851521 cites W2105528101 @default.
• W2045851521 cites W2135947790 @default.
• W2045851521 cites W2140746183 @default.
• W2045851521 cites W2142279946 @default.
• W2045851521 cites W2145122945 @default.
• W2045851521 cites W2149477053 @default.
• W2045851521 cites W2149955599 @default.
• W2045851521 cites W2161289668 @default.
• W2045851521 cites W2161906126 @default.
• W2045851521 cites W2418556477 @default.
• W2045851521 doi "https://doi.org/10.1007/s11060-015-1771-8" @default.
• W2045851521 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4606458" @default.
• W2045851521 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25920709" @default.
• W2045851521 hasPublicationYear "2015" @default.
• W2045851521 type Work @default.
• W2045851521 sameAs 2045851521 @default.
• W2045851521 citedByCount "9" @default.
• W2045851521 countsByYear W20458515212012 @default.
• W2045851521 countsByYear W20458515212014 @default.
• W2045851521 countsByYear W20458515212016 @default.
• W2045851521 countsByYear W20458515212017 @default.
• W2045851521 countsByYear W20458515212018 @default.
• W2045851521 countsByYear W20458515212019 @default.
• W2045851521 countsByYear W20458515212022 @default.
• W2045851521 crossrefType "journal-article" @default.
• W2045851521 hasAuthorship W2045851521A5000349777 @default.
• W2045851521 hasAuthorship W2045851521A5002965160 @default.
• W2045851521 hasAuthorship W2045851521A5009476786 @default.
• W2045851521 hasAuthorship W2045851521A5018451725 @default.
• W2045851521 hasAuthorship W2045851521A5024476694 @default.
• W2045851521 hasAuthorship W2045851521A5039932065 @default.
• W2045851521 hasAuthorship W2045851521A5057541817 @default.
• W2045851521 hasAuthorship W2045851521A5070190752 @default.
• W2045851521 hasAuthorship W2045851521A5084965180 @default.
• W2045851521 hasBestOaLocation W20458515212 @default.
• W2045851521 hasConcept C126322002 @default.
• W2045851521 hasConcept C141071460 @default.
• W2045851521 hasConcept C143998085 @default.
• W2045851521 hasConcept C2776694085 @default.
• W2045851521 hasConcept C2776755627 @default.
• W2045851521 hasConcept C2777389519 @default.
• W2045851521 hasConcept C2778227246 @default.
• W2045851521 hasConcept C2778880634 @default.
• W2045851521 hasConcept C2779083369 @default.
• W2045851521 hasConcept C2779429289 @default.
• W2045851521 hasConcept C2779434656 @default.
• W2045851521 hasConcept C2908647359 @default.
• W2045851521 hasConcept C502942594 @default.
• W2045851521 hasConcept C509974204 @default.
• W2045851521 hasConcept C71924100 @default.
• W2045851521 hasConcept C90924648 @default.
• W2045851521 hasConcept C99454951 @default.
• W2045851521 hasConceptScore W2045851521C126322002 @default.
• W2045851521 hasConceptScore W2045851521C141071460 @default.
• W2045851521 hasConceptScore W2045851521C143998085 @default.
• W2045851521 hasConceptScore W2045851521C2776694085 @default.
• W2045851521 hasConceptScore W2045851521C2776755627 @default.
• W2045851521 hasConceptScore W2045851521C2777389519 @default.
• W2045851521 hasConceptScore W2045851521C2778227246 @default.
• W2045851521 hasConceptScore W2045851521C2778880634 @default.
• W2045851521 hasConceptScore W2045851521C2779083369 @default.
• W2045851521 hasConceptScore W2045851521C2779429289 @default.
• W2045851521 hasConceptScore W2045851521C2779434656 @default.
• W2045851521 hasConceptScore W2045851521C2908647359 @default.
• W2045851521 hasConceptScore W2045851521C502942594 @default.
• W2045851521 hasConceptScore W2045851521C509974204 @default.
• W2045851521 hasConceptScore W2045851521C71924100 @default.
• W2045851521 hasConceptScore W2045851521C90924648 @default.
• W2045851521 hasConceptScore W2045851521C99454951 @default.
• W2045851521 hasIssue "1" @default.

• next